Faculty Enterprising Research Award

The award celebrates successful, enduring partnerships with industry, government and other organisation. This award is for researchers who have achieved, or are achieving, excellence in innovation and enterprise. Winners were nominated for the corresponding Vice-Chancellor Award.

2024 Gregory Stewart and Christopher Langmead

The team's research focus is the translation and commercialisation of neuromedicines. In the past five years, Chris & Greg have been a major driver of neuroscience drug discovery, innovation and commercialisation at MIPS, building both pipeline and partnerships through the Neuromedicines Discovery Centre (NDC).

These include: New neuroscience partnership with Servier: Two novel, non-small molecule modality, collaborative programs (ASOs, mAbs) in CNS and neuroinflammation discovery. Co-founding Phrenix Therapeutics, a spin-out with The Florey: Focusing on improving translational relevance in psychiatry, with an emphasis on cognition. NDC pipeline projects, including next-generation serotonin receptor therapeutics: differentiated agonist and PAMs for development in partnership with Pacalis Therapeutics.

The outstanding work of the Neuromedicines Discovery Centre was also recognised in the University research awards where the team won the 2024 Vice-Chancellor’s Award for Excellence in Research Enterprise and/or Commercialisation.